Skip to main content
RecallsAboutBlog

Ascend Laboratories, LLC

Ascend Laboratories, LLC: 7 recalls listed since May 2026 across FDA.

By year

  • 20267

By agency

  • FDA7

By category

  • Drug7

All recalls (7)

Ascend Laboratories Amlodipine and Olmesartan Medoxomil Tablets

Amlodipine and Olmesartan Medoxomil Tablets are out of specification due to dissolution.

Moderate risk, FDA, , Drug dissolving problem

Ascend Laboratories Dabigatran Etexilate Capsules

Dabigatran Etexilate Capsules failed impurity and degradation specifications.

Low risk, FDA, , Drug impurity

Ascend Laboratories Amlodipine and Olmesartan Medoxomil Tablets

Amlodipine and Olmesartan Medoxomil Tablets failed dissolution specifications, with Olmesartan Medoxomil content below specifications.

Moderate risk, FDA, , Drug dissolving problem

Ascend Laboratories Dabigatran Etexilate Capsules

Dabigatran etexilate capsules failed impurity and degradation specifications during stability testing.

Low risk, FDA, , Drug impurity

Ascend Laboratories Minocycline Hydrochloride Extended-Release Tablets

Minocycline Hydrochloride Extended-Release Tablets failed dissolution specifications during testing.

Moderate risk, FDA, , Drug dissolving problem

Ascend Laboratories Amlodipine and Olmesartan Medoxomil Tablets

Amlodipine and Olmesartan Medoxomil Tablets have failed dissolution specifications, with olmesartan medoxomil content below specifications.

Moderate risk, FDA, , Drug dissolving problem

Ascend Laboratories Metoprolol Succinate Extended-Release Tablets

Metoprolol Succinate Extended-Release Tablets fail dissolution specifications.

Moderate risk, FDA, , Drug dissolving problem
Embed this list